FDA recall record

Meridian Bioscience Revogene C. difficile, in vitro diagnostic assay intended for use with recall — FDA Z-1019-2026

The affected lots show a decline in performance over time, which may lead to false-negative results.

Class IIclassification
Z-1019-2026official record ID
Jan 14, 2026report date

Recall record at a glance

Official recordZ-1019-2026
CategoryMedical Device Recalls
ClassificationClass II
FDA record statusOngoing
Recalling firmMeridian Bioscience Inc.
Report dateJan 14, 2026
Recall initiation dateDec 5, 2025
Quantity211 units
LocationCincinnati, OH, United States

Official product description

Revogene C. difficile, in vitro diagnostic assay intended for use with the Revogene instrument, Catalog Number 410300

Why the product was recalled

The affected lots show a decline in performance over time, which may lead to false-negative results.

Distribution information

US Nationwide distribution and the OUS country of Italy.

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.